Get started
Author

Jesús Ruiz‐Idiago

Observed names: J. Ruiz Idiago, J. Ruiz-Idiago, Jesus M Ruiz, Jesus M. Ruiz-Idiago, Jesus Miguel R. Idiago, Jesus Miguel Ruiz Idiago, Jesus Ruiz Idiago, Jesus Ruiz-Idiago, Jesus Ruiz‐Idiago, Jesús M. Ruiz-Idiago, Jesús Miguel Ruiz, Jesús Miguel Ruiz Idiago, Jesús Ruiz-Idiago, Ruiz Idiago, Jesus Miguel, Ruiz Idiago, Jesús, Ruiz-Idiago Jesus, Ruiz-Idiago, J., Ruiz-Idiago, Jesus
Observed institutions: Universitat Autònoma de Barcelona, Instituto Cajal, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental, Fidmag Sisters Hospitallers, Hospital Mare de Déu de la Mercè, Hospital Universitario Ramón y Cajal, European Huntington's Disease Network
OpenAlex ID: A5050656255
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
2012 · J.-M. Lee, E.M. Ramos, et al. · Neurology · 382
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
2017 · Davina J Hensman Moss, Antonio F Pardiñas, et al. · The Lancet Neurology · 310
PDF
Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease
2016 · Saul Martinez-Horta, Jesus Perez-Perez, et al. · Parkinsonism & Related Disorders · 158
Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trial
2020 · Iluminada Corripio, Alexandra Roldán, et al. · EBioMedicine · 101
PDF
Clinical manifestations of intermediate allele carriers in Huntington disease
2016 · Esther Cubo, María A. Ramos-Arroyo, et al. · Neurology · 53
White matter cortico-striatal tracts predict apathy subtypes in Huntington's disease
2019 · Audrey E. De Paepe, Joanna Sierpowska, et al. · NeuroImage Clinical · 46
PDF
Reduced Cancer Incidence in Huntington’s Disease: Analysis in the Registry Study
2018 · Paul McNulty, Richard Pilcher, et al. · Journal of Huntington s Disease · 35
Specific patterns of brain alterations underlie distinct clinical profiles in Huntington's disease
2019 · Clara Garcia-Gorro, Alberto Llera, et al. · NeuroImage Clinical · 30
PDF
An active cognitive lifestyle as a potential neuroprotective factor in Huntington's disease
2018 · Clara Garcia-Gorro, Maria Garau-Rolandi, et al. · Neuropsychologia · 24
Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's disease
2022 · Lori Quinn, Rebecca Playle, et al. · Parkinsonism & Related Disorders · 23
PDF
Utility of the Parkinson’s disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington’s disease
2020 · Cognitive Phenotype Working Group of the European Huntington’s Disease Network, Saul Martinez-Horta, et al. · Journal of Neurology · 21
Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease
2021 · Audrey E. De Paepe, Alberto Ara, et al. · Movement Disorders · 17
F15 Asymptomatic carriers and early stages huntington’s disease patients show an impaired linguistic profile
2016 · Jesús Ruiz-Idiago, Antonia Tovar, et al. · Journal of Neurology Neurosurgery & Psychiatry · 17
Longitudinal analysis of neuropsychiatric symptoms in a large cohort of early-moderate manifest Huntington's disease patients
2022 · Jesús Ruiz-Idiago, Edith Pomarol-Clotet, et al. · Parkinsonism & Related Disorders · 15
PDF
Spanish Validation of the Problem Behaviors Assessment–Short (PBA-s) for Huntington’s Disease
2016 · Jesús M. Ruiz-Idiago, Misericordia Floriach, et al. · Journal of Neuropsychiatry · 15
PDF
Reduced striato‐cortical and inhibitory transcallosal connectivity in the motor circuit of Huntington's disease patients
2017 · Clara Garcia‐Gorro, Ruth de Diego‐Balaguer, et al. · Human Brain Mapping · 12
PDF
Language disintegration in spontaneous speech in Huntington’s disease: a more fine-grained analysis
2019 · Antonia Tovar, Aina Garí Soler, et al. · Journal of Communication Disorders · 10
Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments
2023 · Andrea Horta-Barba, Saul Martinez-Horta, et al. · Journal of Neurology · 8
PDF
Disentangling the neurobiological bases of temporal impulsivity in Huntington's disease
2024 · Helena Pardina‐Torner, Audrey E. De Paepe, et al. · Brain and Behavior · 6
PDF
Delineating apathy profiles in Huntington's disease with the short-Lille Apathy Rating Scale
2022 · Audrey E. De Paepe, Clara Garcia-Gorro, et al. · Parkinsonism & Related Disorders · 6
Corrigendum to “Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease” [Parkinsonism Relat. Disord. 25C (2016) 58–64]
2016 · Saul Martinez-Horta, Jesus Perez-Perez, et al. · Parkinsonism & Related Disorders · 3
PDF
Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington’s Disease
2021 · Andrea Horta-Barba, Saul Martinez-Horta, et al. · Journal of Huntington s Disease · 2
Detection of illicit phrasal movement in Huntington’s disease
2023 · A. Tovar, S. J. Perry, et al. · Language Cognition and Neuroscience · 1
Changes in Gray Matter Volume Predict Longitudinal Development of Apathy in Huntington’s Disease (1488)
2020 · Audrey De Paepe, Alberto Ara, et al. · Neurology · 1
J017 Testing metformin against cognitive decline in patients with Huntington disease
2024 · Marina Pérez Maeso, Francisco Casterá, et al.
PDF
Works count: 46
Citation count: 1,296
H-index: 15
I10-index: 17
Year
Topic
Type